Health News
Best to Treat Stroke Symptoms in a Hospital
Strokes can lead to death or long-term disability. If the symptoms of stroke are caught early and treated, the patient has a much better chance.
Aspirin for the Heart: Go Uncoated
Taking low-dose aspirin daily has been touted for years to lower the risk of heart attack and stroke. Some people show resistance to this therapy in blood tests, but why?
Who's the Drunkest of Them All?
Many Americans may enjoy drinking on New Year's Eve, but they don't top the charts. In fact, the US is not even among the 25 "drunkest" countries in world alcohol consumption rates.
A Weak Heart, a Broken Heart
The mind-body connection is more than just the fact that your mind exists within your body. Researchers are discovering more every day about how the two interact.
Counseling Uncontrolled Hypertension
African Americans have a greater risk of developing hypertension. They also have more trouble controlling it. Providing them extra support services can improve their health and lower blood pressure.
Sudden Death Risk Before Diabetes
Diabetes can increase your risk for all sorts of health issues, including heart problems. According to recent research, people could be faced with the most severe of these problems even before diabetes sets in.
Can We Protect the Heart from Chemo?
Adriamycin ( doxorubicin ) can be a good chemotherapy treatment for breast cancer. But, for some women, it can lead to heart damage. A recent study found a way to predict who is at risk.
FDA Approves Eliquis for Atrial Fibrillation Patients
The US Food and Drug Administration today approved the anti-clotting drug Eliquis ( apixaban ), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
External Options for Heart Failure
Heart failure patients have a new option to prevent sudden cardiac death. They can wear an external monitor that will make sure their heart beats right.
FDA Approves Juxtapid for Homozygous Familial Hypercholesterolemia
Aegerion Pharmaceuticals, Inc. today announced that the US Food & Drug Administration (FDA) has approved JUXTAPID™ ( lomitapide ) capsules as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol ( LDL-C ), total cholesterol ( TC ), apolipoprotein B ( apo B) and non-high density lipoprotein cholesterol ( non-HDL ) in patients with homozygous familial hypercholesterolemia ( HoFH ).